Fundraising Fox

6 Dimensions Capital

Venture capital

Grand Cayman · Seed–Late Stage · 17 people tracked

Also known as 6 DIMENSIONS CAPITAL LIMITED · FRONTLINE BIOVENTURES (HONG KONG) LIMITED · Wuxi Healthcare Ventures · WUXI HEALTHCARE VENTURES MANAGEMENT US LLC

Find your way into 6 Dimensions Capital

11,761 people in our graph share verified history with the 6 Dimensions Capital team — schools, employers, funds. One of them is your warm intro.

Adam Valkinunlockedknows Wei Li · together at Harvard University (overlapped)
×6knows the team · via Stanford University
knows the team · via McKinsey & Company
knows the team · via Harvard University
×3knows the team · via Massachusetts Institute of Technology
Fox Verdict
Sign up to see your fit

Investment thesis

6 Dimensions Capital is a healthcare-focused investment firm with offices in Boston, San Francisco, Hong Kong, and Shanghai. It backs healthcare startups and growth-stage companies operating in the U.S., Europe, China, Israel, and other markets, with an emphasis on life sciences businesses spanning China and the United States.

Source: firm website, verified Sep 1, 2026.

Stage
Seed–Late Stage
HQ
Grand Cayman, CA, US
Instruments
Equity
Founded
2017
AUM
$800M
VC funds
2
Tracked investments
5

Team · 17 people

from curated & public directories
Leyi Wang· Partnerin𝕏
Hongye Sun· Venture Partnerin
Ching Zhu· Promoter
Edward Hu· Promoter
Ge Li· Promoter
Leo Yan· Investorin
Zi Ye· Vice Presidentin

Founder mafia

2 people who came through 6 Dimensions Capital went on to found or lead other companies.

What they invest in

from 4 of 5 portfolio companies

Biotech ×4AI & Machine Learning ×2Deep Tech ×2Healthtech ×2Medical Devices ×2

HQs:United States×4

Investments · 5 tracked

founders shown can be your intro path
Dewpoint Therapeuticsdewpointx.comin𝕏✓ verified

Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.

AI & Machine LearningBiotechDeep TechBoston, US

Richard Young, Ph.D.(Director)Anthony Hyman, Ph.D.(Director)Tony Hyman(Scientific Co-founder)Rick Young(Scientific Co-founder)Elisabeth Leiderman(Executive Officer)inAmeet Nathwani, M.D.(Executive Officer, Director)in

Co-investorsARCH Venture PartnersEcoR1 CapitalSamsara BioCapitalGeneral CatalystInnovation EndeavorsLeaps by Bayer+5 more

TScan Therapeuticstscan.comin𝕏Jul 2019SEC filingmedium confidence

A company focused on developing clinical treatments aimed at improving patient outcomes.

BiotechHealthtechMedical DevicesBoston, US

David Southwell(Executive Officer, Director)inRobert Crane(Executive Officer)

BoardLea Hachigian(Director)Steve Kraus(Director)inCampbell Murray(Director)

Board seatHannes Smarason· per SEC Form D · $23.3M raise · filed Jul 2019

Co-investorsAstellas Venture Management LLCBessemer Venture PartnersLongwood FundRA CapitalLongwood Special SituationsPitango

Hua Medicinehuamedicine.com

Shanghai-based, HKEX-listed drug developer commercializing dorzagliatin, the first approved glucokinase activator for type 2 diabetes.

Co-investorsARCH Venture PartnersF-Prime CapitalVenrockBlue Pool CapitalEight Roads VenturesPing An

Ultivueultivue.comin𝕏Acquired

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Co-investorsARCH Venture PartnersNorthpond VenturesApplied VenturesKilonova CapitalPura Vida InvestmentsRazor's Edge Ventures+2 more

Viela Bio

BiotechGaithersburg, US

Zhengbin (Bing) Yao(Chief Executive Officer and Secretary)Matthew Pietras(Treasurer)Yanling Cao(Director)Wenkai Xiang(Director)Bahija Jallal(Director)Ting Jia(Director)

Co-investorsBoyu CapitalGoldman SachsHillhouse Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does 6 Dimensions Capital invest at?
6 Dimensions Capital invests at the Seed, Series A, Series B, Growth, Late Stage stages.
What sectors does 6 Dimensions Capital focus on?
6 Dimensions Capital focuses on Biotech, Healthtech, Medical Devices, New Materials.
Where is 6 Dimensions Capital located?
6 Dimensions Capital is headquartered in Grand Cayman, US.

Co-investors · 17

ARCH Venture Partners

ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.

$50K – $250M
Bessemer Venture Partners

Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

Both backed · 1
$5M – $100M
Northpond Ventures

Northpond Ventures is a venture capital firm based in Bethesda, Maryland that invests in life sciences, technology, and related sectors.

Both backed · 1
$100K – $5M
Andreessen Horowitz

Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.

$500K – $50M
Sequoia Capital

Sequoia Capital is a venture capital firm that partners with founders to build technology companies.

$4.4M – $214M
Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

$500K – $5M
Lightspeed Venture Partners

Lightspeed is a global venture capital firm that has spent over two decades backing innovative companies as an early and first investor.

$1.7M – $87M
Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M
DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M
Operator LP

Operator Partners is an investment firm run by operators that invests its own capital in technology companies from inception through Series B.

$200K – $500K
AlleyCorp

AlleyCorp is an early-stage investor and incubator based in New York that builds and backs companies across enterprise, consumer, healthcare, and deep tech sectors.

$1M – $5M
OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

$1M – $75M
5 more co-investors

Octopus VenturesDimension CapitalMPM BioImpactNovo HoldingsSuperSeed

Firms observed investing alongside 6 Dimensions Capital, from public investor directories. Shared companies are the overlap with 6 Dimensions Capital's recorded portfolio.

Similar investors

Featured in lists